News

First-bite syndrome: a novel complication of carotid body paraganglioma resection


 

Alyssa Trenery,1 Zaina P. Qureshi, PhD, MPH,2,3 Randall Rowen, PharmD,2 Terry Day, MD,4,5 LeAnn Norris, PharmD,2 and Charles L. Bennett, MD, PhD, MPP2,3,4
1 College of Arts and Sciences, University of South Carolina, Columbia, SC; 2 The South Carolina Center of Economic Excellence for Medication Safety, South Carolina College of Pharmacy, Columbia, SC; 3 Health Services, Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, SC; 4 Hollings Cancer Center of the Medical University of South Carolina, Charleston, SC; and 5 Head and Neck Tumor Center, Medical University of South Carolina, Charleston, SC

First-bite syndrome is a relatively uncommon and recently identified problem associated with surgery involving the parotid gland, neck tumors, parapharyngeal- space masses, and paragangliomas. Treatments for first-bite syndrome offer variable results, with botulinum toxin being perhaps the most promising option.

Case presentation
A 55-year-old man was referred for excision of an asymptomatic left parapharyngeal mass thought to be a carotid body paraganglioma. The patient had been treated previously with antibiotics for a possible sinus infection, without resolution. He underwent CT and angiographic embolization of the tumor prior to excision of the mass. Pretreatment imaging was consistent with a carotid body tumor. The patient was presented with treatment options, including surgical resection.

Preoperatively, the surgeon informed the patient of the potential for neurologic and cranial nerverelated complications and other perioperative risks. Surgery was performed via a transcervical incision. Through careful subadventitial dissection, the tumor was separated from the carotid artery and the carotid artery bifurcation. Excision of the tumor involved separation from and/or mobilization of the marginal mandibular branch of the facial nerve, hypoglossal nerve, spinal accessory nerve, glossopharyngeal nerve, and vagus nerve but was free of the sympathetic trunk and ganglion. However, the tumor was attached to and required ligation of the external carotid artery.

A few days after surgery, the patient experienced pain in his left jaw and ear immediately upon ingesting the first bite of solid food. The sensation was described as a “strong electrical jolt” with severe cramping, which was initially painful but then slowly dissipated after 5–15 minutes. In addition, the patient reported that the pain returned a few minutes after eating and persisted for up to 15 minutes.

About 2 weeks after surgery, the postprandial pain began to diminish in intensity, with complete resolution about 3 weeks thereafter. The first-bite syndrome pain, however, continued with similar intensity and duration 3.5 months post surgery. Selftreatment with acetaminophen and ibuprofen did not eliminate the pain.


Background discussion
First-bite syndrome is a relatively uncommon and recently identified problem associated with surgeries involving the parotid gland and/or the parapharyngeal space.1 The current description of the syndrome was initially reported in 1998 by Netterville,2 and the term “first-bite” syndrome was thought to be an appropriate name for the findings. In 1986, a gastrointestinal surgeon, Haubrich, had associated “first-bite syndrome” with a different clinical syndrome: esophageal dysfunction in patients who complained of an inability to swallow the first few bites of a meal ac companied by retrosternal pain. These individuals’ symptoms were relieved by regurgitation. 3

The true incidence of “first-bite syndrome” as characterized by Netterville is unknown, but cases have been reported after surgery of the parotid gland, neck tumors, parapharyngeal-space masses, and paragangliomas (Table 1).4–7 Those with the syndrome typically develop an intense, sharp, and sometimes cramping pain in the ipsilateral parotid region after the first bite of each meal.3 The severe pain lessens with each subsequent bite of the meal only to return at the first bite of the next meal.2

Netterville et al2 proposed that firstbite syndrome is due to the loss of sympathetic innervation to the parotid gland, resulting in the denervation and supersensitivity of the sympathetic receptors that control the myoepithelial cells. The pain comes from a supramaximal response of the myoepithelial cells stimulated by parasympathetic neurotransmitters, causing a spasm with the initial intake of food after a period of salivary rest (Figure 1). This etiology holds true in the majority of cases, although not all. A common feature for those afflicted with first-bite syndrome is residual parotid gland tissue. In some cases, even the thought of eating may cause a reaction by the salivary glands.

Tumors of the parapharyngeal space are rare; they typically evade diagnosis until found incidentally on imaging for another reason or grow to a size that becomes symptomatic or deforming. Imaging should be performed to evaluate the extent of the mass in the parapharyngeal area and the surrounding vascular structures preoperatively and to assure appropriate surgical planning and patient advisement.1 Biopsy is not recommended for carotid body tumors due to the risk of vascular injury, bleeding, and more severe complications.

Common surgical procedures that a b can result in first-bite syndrome include parotidectomy, neck dissection, transcervical excision of a sympathetic chain schwannoma, paraganglioma excision, and excision of a deep lobe parotid pleomorphic adenoma.8 In a retrospective study by Kawashima et al,4 9 of 22 patients who underwent surgery to remove a tumor in the parapharyngeal space postoperatively developed first-bite syndrome. All five patients who had external carotid artery ligation and resection of the deep lobe in the parotid gland during surgery developed first-bite syndrome. One patient underwent ligation of the external carotid artery from the sympathetic pathway and ligation of the auriculotemporal nerve from the parasympathetic pathway (Figure 1) and did not develop first-bite syndrome.

Pages

Recommended Reading

FDA Approves First Drug for Medullary Thyroid Cancer
MDedge Hematology and Oncology
BRAF Mutation Status May Change Papillary Thyroid Cancer Management
MDedge Hematology and Oncology
Smoking Cessation Can Reduce Late Side Effects of Radiotherapy
MDedge Hematology and Oncology
Two Factors Predict Postradiotherapy Swallowing Difficulties
MDedge Hematology and Oncology
Low EGFR Expression Predicts ARCON Benefit in Laryngeal Cancer
MDedge Hematology and Oncology
Larynx Preservation Studies Should Consider Treatment Impact
MDedge Hematology and Oncology
Feasibility and acceptance of a telehealth intervention to promote symptom management during treatment for head and neck cancer
MDedge Hematology and Oncology
Head & Neck Cancers
MDedge Hematology and Oncology
HPV-Related Oral Cancer Incidence Spikes Sharply
MDedge Hematology and Oncology
HPV-Related Oral Cancer Incidence Spikes Sharply
MDedge Hematology and Oncology